本页面由Tiger Trade Technology Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

7.40
-0.4250-5.43%
成交量:67.01万
成交额:502.75万
市值:6.45亿
市盈率:-3.47
高:7.77
开:7.77
低:7.39
收:7.82
52周最高:36.26
52周最低:6.65
股本:8,715.70万
流通股本:7,188.81万
量比:0.70
换手率:0.93%
股息:- -
股息率:- -
每股收益(TTM):-2.1289
每股收益(LYR):-1.8700
净资产收益率:-52.74%
总资产收益率:-31.82%
市净率:1.50
市盈率(LYR):-3.95

数据加载中...

2026/03/16

重要事件披露

Form 8-K - Current report
2026/03/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/02/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/30

重要事件披露

Form 8-K - Current report
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report